When was Bioniq founded?

Bioniq was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Where is Bioniq located?

Bioniq is headquartered in London, United Kingdom. It is registered at ACRE HOUSE,11/15 WILLIAM ROAD,LONDON,UNITED KINGDOM,NW1 3ER.

Which legal entities is Bioniq associated with?

Bioniq is associated with BQ HOLDING LTD and 1 other.

How many employees does Bioniq have?

As of Aug 31, 2026, the latest employee count at Bioniq is 53.

Is Bioniq a funded company?

Bioniq is a funded company, having raised a total of $34.2M across 7 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on 2020.

How much is Bioniq worth?

The latest valuation of Bioniq is £***** as of Nov 18, 2025.

When was the latest funding round of Bioniq?

Bioniq's latest funding was a $***** Series B round on Jul 16, 2025, with participation from 0 investor.

Where does Bioniq rank among its competitors?

Bioniq ranks 1st amongst 40 active competitors, of which 15 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Bioniq, which secured $3.09M in Jul, 2025.

Who are the top competitors of Bioniq?

Bioniq's top competitors include Zoe, Flore and Mybacs. Among them, Bioniq secured the most recent funding round in July, 2025.

Bioniq - 2026 Company Profile, Team, Funding, Competitors & Financials

Bioniq is a series B company based in London (United Kingdom), founded in 2019 by Vadim Fedotov. It operates as a Provider of personalized nutritional supplements using patented Swiss granules. Bioniq has raised $34.2M in funding from investors like MedsiGroup, HV Capital and Unbound, with a current valuation of £*****. The company has 40 active competitors, including 15 funded and 1 that has exited. Its top competitors include companies like Zoe, Flore and Mybacs.

Company Details

Provider of personalized nutritional supplements using patented Swiss granules. These products consist of vitamins, minerals, and prebiotic fibers designed for daily consumption. The formulas are created based on individual health assessments or biological analysis to address specific wellness requirements. The granules utilize a sustained release technology to facilitate nutrient absorption within the digestive tract. The production process adheres to regulatory standards for safety and quality control. Each batch is prepared to meet the specific health profile of the recipient.

Website: www.bioniq.com/
Social
Email ID: *****@bioniq.com
Phone Number: +44 **********
Registered Address: ACRE HOUSE,11/15 WILLIAM ROAD,LONDON,UNITED KINGDOM,NW1 3ER

Key Metrics

Founded Year

2019

Location

London, United Kingdom

Stage

Series B

Total Funding

$34.2M in 7 rounds

Latest Funding Round

Series B, Jul 16, 2025, $*****

Post Money Valuation

£***** as on Nov 18, 2025

Investors

MedsiGroup & 14 more

Ranked

1^st among 40 active competitors

Employee Count

53 as on Aug 31, 2026

Investment & Acquisitions

VAHA & 1 more

Similar Companies

Zoe & 44 more

View Bioniq's full profile

Bioniq is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIONIQ HEALTH-TECH SOLUTIONS LIMITED CIN: 11781130 , United Kingdom, Active	Jan 21, 2019	-	14 (As on Dec 31, 2024)
BQ HOLDING LTD CIN: 14319526 , United Kingdom, Active	Aug 25, 2022	-	-

Bioniq has raised a total funding of $34.2M over 7 rounds. Its first funding round was on 2020. Bioniq has 14 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Bioniq:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 16, 2025	6748266	Series B	2025966	2759807	6391364	4942431
Mar 18, 2025	1473849	Angel	7587201	8480598	7692887	5391746
Oct 22, 2024	2632940	Angel	5772862	4742634	5647872	Cristiano Ronaldo

Access funding benchmarks and valuations. Sign up today!

View details of Bioniq's funding rounds and investors

The founders of Bioniq is Vadim Fedotov. Oliver Motisi is the CEO of Bioniq.

Here are the details of Bioniq's key team members:

Vadim Fedotov: Co-Founder & President of Bioniq.
Oliver Motisi: CEO of Bioniq.
Contact Info: 1 email address

Bioniq's Board of Directors

Bioniq's board has 6 active members. Oliver Antonio Motisi is part of team and James Hardy, Shravin Bharti Mittal, Levin Joseph, Vadim Fedotov and Vikram Dhingra are independent board members.

Here is the list of Bioniq's board of directors:

Name	Type	Representing	Status	Duration
qhqywhv	Team	-	Current	4y 5m
James Hardy	Independent board member	-	Current	3y 10m
rqxiu{b	Independent board member	-	Current	3y 6m
rrqzutv	Independent board member	-	Current	5y 8m
arrtviw	Independent board member	-	Current	3y 9m
ebrhyiw	Independent board member	-	Current	3y 1m

View details of Bioniq's Founder profiles and Board Members

Bioniq's employee count trend

Bioniq has 53 employees as of Aug 26. Here is Bioniq's employee count trend over the years:

Uncover Bioniq's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Bioniq include Zoe, Flore and Mybacs. Here is the list of Top 10 competitors of Bioniq, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bioniq 2019, London (United Kingdom), Series B	Provider of personalized nutritional supplements using patented Swiss granules	$34.2M	HV Capital, TQ Ventures & 13 others	63/100
2nd	Zoe 2017, New Castle (United States), Late Stage	Provider of gut health testing services and plant based supplements	$133M	Balderton Capital, Ahren & 12 others	57/100
3rd	Flore 2016, San Diego (United States), Series A	Provide nutritional supplements to improve gut health	$21.1M	Pangaea Ventures, K3 & 11 others	49/100
4th	Mybacs 2018, Baar (Switzerland), Series A	Manufacturer of probiotic products for digestion	$5.92M	Global Founders Capital, naturalX Health Ventures ... & 7 others	45/100
5th	Alba Health 2022, Stockholm (Sweden), Seed	Provider of personalized nutrition plans and coaching services for children	$4.5M	Voima Ventures, Unconventional Ventures & 8 others	43/100
6th	Baze 2014, Berlin (Germany), Acquired	Personalized vitamin supplements based on biochemical tests	$6M	Nature's Way, b2venture & 4 others	42/100
7th	Elo Health 2020, San Francisco (United States), Series A	Provider of personalized supplements based on biochemical analysis	$18.5M	Gullspang Re:food, Octopus Ventures & 14 others	42/100
8th	Ombre 2016, San Francisco (United States), Seed	Provider of microbiome-based personalized supplements	$9.5M	PivotNorth Capital, Abstract Ventures & 13 others	40/100
9th	Sundose 2018, London (United Kingdom), Series A	Provider of personalized supplements to improve health	$7.19M	Delivery Hero Ventures, Investible & 6 others	38/100
10th	Rootine 2018, Nashville (United States), Series A	Provider of personalized nutrition supplements	$14.5M	Relevance Ventures, DSM & 8 others	38/100